Adamantinoma

Changed by Liz Silverstone, 16 Mar 2024
Disclosures - updated 6 Dec 2023: Nothing to disclose

Updates to Article Attributes

Body was changed:

Adamantinomas are rare indolent malignant bone tumours with a predilection for the tibial diaphysis. Following excision, local recurrence can be problematic and may occur after an interval of decades. Lymphadenopathy and metastases complicate <30% of cases 12.

Terminology

Ameloblastomas, which are benign locally aggressive bone tumours of the mandible, were previously also known as adamantinomas of the mandible. Although the histology is similar, a common histogenesis is unproven.

Epidemiology

Adamantinomas account for <1% of primary bone tumours and typically present between the 2nd and 5th decades. There is a slight male predilection (M:F = 5:4) 12.

Clinical presentation

Symptoms of pain, swelling and tibial bowing deformity are slowly progressive. Pathological fracture presents acutely.

A history of prior local trauma may be elicited in around 60%. Paraneoplastic severe hypercalcaemia with coma and pancreatitis have been reported 12.

Almost all cases occur in long bones and up to 85% occur in the mid tibial shaft. Some occur in the tibial metaphysis and up to 15% concurrently involve the fibula. Occasionally tumours arise in the fibula alone, the humerus, hand, foot, radius, femur, ribs, spine, facial bones andor pretibial soft-tissues are involved 12.

Pathology

The histogenesis remains the subject of debate. The histology is heterogeneous and epithelial, synovial, endothelial and osseofibrous components have been demonstrated. Transformation of osseofibrous dysplasia or angioblastic derivation have been proposed. Extensive sampling of the most radiolucent areas is recommended for diagnosis 12.

Subtypes are distinguished by degree of differentiation, osseofibrous component, Ewing’s sarcoma-like components or areas of squamous cell carcinoma 12.

Tumours are positive for cytokeratins 5, 14 and 19, and the stromal component is positive for vimentin.

Radiographic features

The tumour is typically well-circumscribed, expansile and multiloculated with a thin sclerotic rim and involves the anterior tibial diaphyseal cortex. It can spread into the medullary canal and soft-tissues. There may be multiple tumour nodules and concurrent involvement of the fibula.

Plain radiograph / CT

Typically, it appears as a multilocular or slightly expansile osteolytic cortical lesion. This may be visualised as areas of lysis interspersed with areas of sclerosis 3. Lesions tend to have an eccentric epicentre 4 and a lack of periosteal reaction. Tumours may be locally aggressive disease at presentation.

MRI

MRI is essential to define disease extent pre-operatively. The disease may be unifocal or present as multiple nodules.

  • solitary lobulated focus 

  • multiple small nodules in onemultinodular with skip lesions or more foci periosteal involvement.

In some patients separated tumour foci may be seen, defined as foci ofTumour demonstrates high signal intensity on either T2- or contrast-enhanced T1-weighted images, interspersed with normal-appearing cortical or cancellous bone 2. A fluid-fluid level may occasionally be seen.

  • T1 C+ (Gd): tends to show intense and homogeneous static enhancement, although there is no uniform dynamic enhancement pattern 2

FDG PET-CT

Lesions are FDG aavid.

Treatment and prognosis

Surgical en bloc resection with wide margins and subsequent reconstruction is preferred. Amputation is sometimes necessary particularly for local recurrence. Curettage should be avoided due to a high incidence of local recurrence.

Local recurrence has been described up to 36 years post resection and metastases occur in 15-30% of patients affecting lymph nodes, lungs, bone, liver, other abdominal viscera, retroperitoneum and pericardium.

10-year survival may be as high as 92% and recurrence-free survival approximately 72%. The optimal duration and frequency of follow-up has not been defined.

History and etymology

Adamantinoma is derived from the Greek word "adamantinos", which means "very hard". It was first observed in the shaft of an ulna in 1900 by C Maier 8, who believed it was a carcinoma, although the term "adamantinoma" was coined by B Fisher in 1913 9.

Differential diagnosis

Imaging differential considerations include 6:

  • -<p><strong>Adamantinomas</strong>&nbsp;are rare indolent malignant bone tumours with a predilection for the tibial diaphysis. Following excision, local recurrence can be problematic and may occur after an interval of decades. Lymphadenopathy and metastases complicate &lt;30% of cases <sup>12</sup>.</p><h4>Terminology</h4><p><a href="/articles/ameloblastoma" title="Ameloblastoma">Ameloblastomas</a>, which are benign locally aggressive bone tumours of the mandible, were previously also known as adamantinomas of the mandible. Although the histology is similar, a common histogenesis is unproven.</p><h4>Epidemiology</h4><p>Adamantinomas account for &lt;1% of primary bone tumours and typically present between the 2<sup>nd</sup> and 5<sup>th</sup> decades. There is a slight male predilection (M:F = 5:4) <sup>12</sup>.</p><h4>Clinical presentation</h4><p>Symptoms of pain, swelling and tibial bowing deformity are slowly progressive. Pathological fracture presents acutely.</p><p>A history of prior local trauma may be elicited in around 60%. Paraneoplastic severe hypercalcaemia with coma and pancreatitis have been reported <sup>12</sup>.</p><p>Almost all cases occur in long bones and up to 85% occur in the mid tibial shaft. Some occur in the tibial metaphysis and up to 15% concurrently involve the fibula. Occasionally the fibula alone, the humerus, hand, foot, radius, femur, ribs, spine, facial bones and pretibial soft-tissues are involved <sup>12</sup>.</p><h4>Pathology</h4><p>The histogenesis remains the subject of debate. The histology is heterogeneous and epithelial, synovial, endothelial and osseofibrous components have been demonstrated. Transformation of osseofibrous dysplasia or angioblastic derivation have been proposed. Extensive sampling of the most radiolucent areas is recommended for diagnosis <sup>12</sup>.</p><p>Subtypes are distinguished by degree of differentiation, osseofibrous component, Ewing’s sarcoma-like components or areas of squamous cell carcinoma <sup>12</sup>.</p><p>Tumours are positive for cytokeratins 5, 14 and 19, and the stromal component is positive for vimentin.</p><h4>Radiographic features</h4><p>The tumour is typically well-circumscribed, expansile and multiloculated with a thin sclerotic rim and involves the anterior tibial diaphyseal cortex. It can spread into the medullary canal and soft-tissues. There may be multiple nodules and concurrent involvement of the fibula.</p><h5>Plain radiograph / CT</h5><p>Typically, it appears as a multilocular or slightly expansile osteolytic cortical lesion. This may be visualised as areas of lysis interspersed with areas of sclerosis <sup>3</sup>. Lesions tend to have an eccentric epicentre <sup>4</sup>&nbsp;and a lack of <a href="/articles/periosteal-reaction">periosteal reaction</a>. Tumours may be locally aggressive disease at presentation.</p><h5>MRI</h5><p>MRI is essential to define disease extent pre-operatively. The disease may be unifocal or present as multiple nodules.</p><ul>
  • -<li><p>solitary lobulated focus&nbsp;</p></li>
  • -<li><p>multiple small nodules in one or more foci&nbsp;</p></li>
  • -</ul><p>In some patients separated tumour foci may be seen, defined as foci of high signal intensity on either T2 or contrast-enhanced T1-weighted images, interspersed with normal-appearing <a href="/articles/cortical-bone" title="Cortical bone">cortical</a> or <a href="/articles/cancellous-bone">cancellous bone</a>&nbsp;<sup>2</sup>.&nbsp;A fluid-fluid level may occasionally be seen.</p><ul><li><p><strong>T1 C+ (Gd):</strong> tends to show intense and homogeneous static enhancement, although there is no uniform dynamic enhancement pattern <sup>2</sup></p></li></ul><h4>FDG PET-CT</h4><p>Lesions are FDG a</p><h4>Treatment and prognosis</h4><p>Surgical en bloc resection with wide margins and subsequent reconstruction is preferred. Amputation is sometimes necessary particularly for local recurrence. Curettage should be avoided due to a high incidence of local recurrence.</p><p>Local recurrence has been described 36 years post resection and metastases occur in 15-30% of patients affecting lymph nodes, lungs, bone, liver, other abdominal viscera, retroperitoneum and pericardium.</p><h4>History and etymology</h4><p>Adamantinoma is derived from the Greek word "adamantinos", which means "very hard". It was first observed in the shaft of an ulna in 1900 by C Maier <sup>8</sup>, who believed it was a carcinoma, although the term "adamantinoma" was coined by B Fisher in 1913 <sup>9</sup>.</p><h4>Differential diagnosis</h4><p>Imaging differential considerations include <sup>6</sup>:</p><ul>
  • +<p><strong>Adamantinomas</strong>&nbsp;are rare indolent malignant bone tumours with a predilection for the tibial diaphysis. Following excision, local recurrence can be problematic and may occur after an interval of decades. Lymphadenopathy and metastases complicate &lt;30% of cases <sup>12</sup>.</p><h4>Terminology</h4><p><a href="/articles/ameloblastoma" title="Ameloblastoma">Ameloblastomas</a>, which are benign locally aggressive bone tumours of the mandible, were previously also known as adamantinomas of the mandible. Although the histology is similar, a common histogenesis is unproven.</p><h4>Epidemiology</h4><p>Adamantinomas account for &lt;1% of primary bone tumours and typically present between the 2<sup>nd</sup> and 5<sup>th</sup> decades. There is a slight male predilection (M:F = 5:4) <sup>12</sup>.</p><h4>Clinical presentation</h4><p>Symptoms of pain, swelling and tibial bowing deformity are slowly progressive. Pathological fracture presents acutely.</p><p>A history of prior local trauma may be elicited in around 60%. Paraneoplastic severe hypercalcaemia and pancreatitis have been reported <sup>12</sup>.</p><p>Almost all cases occur in long bones and up to 85% occur in the mid tibial shaft. Some occur in the tibial metaphysis and up to 15% concurrently involve the fibula. Occasionally tumours arise in the fibula alone, the humerus, hand, foot, radius, femur, ribs, spine, facial bones or pretibial soft-tissues <sup>12</sup>.</p><h4>Pathology</h4><p>The histogenesis remains the subject of debate. The histology is heterogeneous and epithelial, synovial, endothelial and osseofibrous components have been demonstrated. Transformation of osseofibrous dysplasia or angioblastic derivation have been proposed. Extensive sampling of the most radiolucent areas is recommended for diagnosis <sup>12</sup>.</p><p>Subtypes are distinguished by degree of differentiation, osseofibrous component, Ewing’s sarcoma-like components or areas of squamous cell carcinoma <sup>12</sup>.</p><p>Tumours are positive for cytokeratins 5, 14 and 19, and the stromal component is positive for vimentin.</p><h4>Radiographic features</h4><p>The tumour is typically well-circumscribed, expansile and multiloculated with a thin sclerotic rim and involves the anterior tibial diaphyseal cortex. It can spread into the medullary canal and soft-tissues. There may be multiple tumour nodules and concurrent involvement of the fibula. </p><h5>Plain radiograph / CT</h5><p>Typically, it appears as a multilocular or slightly expansile osteolytic cortical lesion. This may be visualised as areas of lysis interspersed with areas of sclerosis <sup>3</sup>. Lesions tend to have an eccentric epicentre <sup>4</sup>&nbsp;and a lack of <a href="/articles/periosteal-reaction">periosteal reaction</a>. Tumours may be locally aggressive at presentation.</p><h5>MRI</h5><p>MRI is essential to define disease extent pre-operatively. The disease may be unifocal or multinodular with skip lesions or periosteal involvement.</p><p>Tumour demonstrates high signal intensity on T2- or contrast-enhanced T1-weighted images, interspersed with normal-appearing <a href="/articles/cortical-bone" title="Cortical bone">cortical</a> or <a href="/articles/cancellous-bone">cancellous bone</a>&nbsp;<sup>2</sup>.&nbsp;A fluid-fluid level may occasionally be seen.</p><h4>FDG PET-CT</h4><p>Lesions are FDG avid.</p><h4>Treatment and prognosis</h4><p>Surgical en bloc resection with wide margins and subsequent reconstruction is preferred. Amputation is sometimes necessary particularly for local recurrence. Curettage should be avoided due to a high incidence of local recurrence.</p><p>Local recurrence has been described up to 36 years post resection and metastases occur in 15-30% of patients affecting lymph nodes, lungs, bone, liver, other abdominal viscera, retroperitoneum and pericardium.</p><p>10-year survival may be as high as 92% and recurrence-free survival approximately 72%. The optimal duration and frequency of follow-up has not been defined.</p><h4>History and etymology</h4><p>Adamantinoma is derived from the Greek word "adamantinos", which means "very hard". It was first observed in the shaft of an ulna in 1900 by C Maier <sup>8</sup>, who believed it was a carcinoma, although the term "adamantinoma" was coined by B Fisher in 1913 <sup>9</sup>.</p><h4>Differential diagnosis</h4><p>Imaging differential considerations include <sup>6</sup>:</p><ul>
Images Changes:

Image 2 X-ray (Frontal) ( destroy )

Caption was removed:
Case 1
Ddx was removed.
Position was removed.

Image 2 X-ray (Lateral) ( update )

Caption was changed:
Case 2

Image 3 MRI (STIR) ( destroy )

Caption was removed:
Case 1
Ddx was removed.
Position was removed.

Image 3 MRI (Gradient Echo) ( update )

Caption was changed:
Case 3

Image 4 MRI (T2) ( destroy )

Caption was removed:
Case 1
Ddx was removed.
Position was removed.

Image 4 MRI (T1 C+ fat sat) ( update )

Caption was changed:
Case 4

ADVERTISEMENT: Supporters see fewer/no ads

Updating… Please wait.

 Unable to process the form. Check for errors and try again.

 Thank you for updating your details.